

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 6.13504949 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.10249690 |
| 3 | endothelium development (GO:0003158) | 5.08797303 |
| 4 | blood vessel maturation (GO:0001955) | 5.08256405 |
| 5 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.95570798 |
| 6 | surfactant homeostasis (GO:0043129) | 4.82243286 |
| 7 | barbed-end actin filament capping (GO:0051016) | 4.70830846 |
| 8 | lymphangiogenesis (GO:0001946) | 4.65214542 |
| 9 | morphogenesis of an endothelium (GO:0003159) | 4.37813494 |
| 10 | endothelial tube morphogenesis (GO:0061154) | 4.37813494 |
| 11 | positive regulation of vasculogenesis (GO:2001214) | 4.34847687 |
| 12 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.14851983 |
| 13 | regulation of mononuclear cell migration (GO:0071675) | 4.11604710 |
| 14 | regulation of endothelial cell differentiation (GO:0045601) | 4.01062048 |
| 15 | virion attachment to host cell (GO:0019062) | 3.99323066 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 3.99323066 |
| 17 | basement membrane organization (GO:0071711) | 3.94418629 |
| 18 | heart trabecula formation (GO:0060347) | 3.90171313 |
| 19 | apoptotic cell clearance (GO:0043277) | 3.89833898 |
| 20 | regulation of macrophage chemotaxis (GO:0010758) | 3.76766674 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.75784159 |
| 22 | glomerular filtration (GO:0003094) | 3.69813624 |
| 23 | renal filtration (GO:0097205) | 3.66506884 |
| 24 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.66357496 |
| 25 | regulation of vasculogenesis (GO:2001212) | 3.63874646 |
| 26 | hyaluronan catabolic process (GO:0030214) | 3.63341129 |
| 27 | blood vessel endothelial cell migration (GO:0043534) | 3.62262735 |
| 28 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.54396633 |
| 29 | endothelial cell morphogenesis (GO:0001886) | 3.51259728 |
| 30 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.47770061 |
| 31 | chemical homeostasis within a tissue (GO:0048875) | 3.47316783 |
| 32 | protein localization to endosome (GO:0036010) | 3.46755413 |
| 33 | lysine catabolic process (GO:0006554) | 3.42905080 |
| 34 | lysine metabolic process (GO:0006553) | 3.42905080 |
| 35 | endodermal cell differentiation (GO:0035987) | 3.38365476 |
| 36 | cardiac myofibril assembly (GO:0055003) | 3.33265682 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 3.32248958 |
| 38 | pinocytosis (GO:0006907) | 3.32055805 |
| 39 | glomerular basement membrane development (GO:0032836) | 3.30846717 |
| 40 | endothelial cell chemotaxis (GO:0035767) | 3.30125858 |
| 41 | positive regulation of receptor recycling (GO:0001921) | 3.29866281 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.28498522 |
| 43 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.27157794 |
| 44 | glomerular visceral epithelial cell development (GO:0072015) | 3.24211689 |
| 45 | stress fiber assembly (GO:0043149) | 3.24208630 |
| 46 | glycosphingolipid catabolic process (GO:0046479) | 3.23513617 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.23195383 |
| 48 | substrate-dependent cell migration (GO:0006929) | 3.22509667 |
| 49 | keratan sulfate catabolic process (GO:0042340) | 3.17830551 |
| 50 | mannose metabolic process (GO:0006013) | 3.17191199 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16620432 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16620432 |
| 53 | sarcomere organization (GO:0045214) | 3.15997175 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13210866 |
| 55 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.12908314 |
| 56 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.10789331 |
| 57 | fatty acid beta-oxidation (GO:0006635) | 3.10524306 |
| 58 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.10482274 |
| 59 | transcytosis (GO:0045056) | 3.10230534 |
| 60 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.09892158 |
| 61 | carnitine shuttle (GO:0006853) | 3.08648552 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06633805 |
| 63 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.06022841 |
| 64 | response to thyroid hormone (GO:0097066) | 3.05834024 |
| 65 | response to magnesium ion (GO:0032026) | 3.05752711 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 3.01030689 |
| 67 | valine metabolic process (GO:0006573) | 3.00590365 |
| 68 | sprouting angiogenesis (GO:0002040) | 2.98272813 |
| 69 | ovulation from ovarian follicle (GO:0001542) | 2.97933522 |
| 70 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.96074756 |
| 71 | amino sugar catabolic process (GO:0046348) | 2.94518546 |
| 72 | wound healing, spreading of epidermal cells (GO:0035313) | 2.93802920 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93782503 |
| 74 | response to mercury ion (GO:0046689) | 2.91688188 |
| 75 | negative regulation of focal adhesion assembly (GO:0051895) | 2.89991024 |
| 76 | negative regulation of cell junction assembly (GO:1901889) | 2.89991024 |
| 77 | negative regulation of adherens junction organization (GO:1903392) | 2.89991024 |
| 78 | endothelial cell differentiation (GO:0045446) | 2.89738200 |
| 79 | fibril organization (GO:0097435) | 2.89437308 |
| 80 | regulation of early endosome to late endosome transport (GO:2000641) | 2.89305541 |
| 81 | coronary vasculature morphogenesis (GO:0060977) | 2.88605886 |
| 82 | response to peptidoglycan (GO:0032494) | 2.88520369 |
| 83 | protein heterotrimerization (GO:0070208) | 2.88204448 |
| 84 | glycolipid catabolic process (GO:0019377) | 2.87395066 |
| 85 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.86826219 |
| 86 | extracellular fibril organization (GO:0043206) | 2.85885053 |
| 87 | definitive hemopoiesis (GO:0060216) | 2.84871795 |
| 88 | tricarboxylic acid metabolic process (GO:0072350) | 2.83281482 |
| 89 | negative regulation of endothelial cell migration (GO:0010596) | 2.81133423 |
| 90 | glomerular epithelial cell development (GO:0072310) | 2.80755056 |
| 91 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.80139367 |
| 92 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.79433235 |
| 93 | regulation of monocyte chemotaxis (GO:0090025) | 2.79273313 |
| 94 | fatty acid oxidation (GO:0019395) | 2.78711982 |
| 95 | positive regulation of extracellular matrix organization (GO:1903055) | 2.78469921 |
| 96 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.77601126 |
| 97 | glial cell migration (GO:0008347) | 2.77083283 |
| 98 | glyoxylate metabolic process (GO:0046487) | 2.75916806 |
| 99 | negative regulation of platelet activation (GO:0010544) | 2.75702022 |
| 100 | skin morphogenesis (GO:0043589) | 2.75245095 |
| 101 | ethanol oxidation (GO:0006069) | 2.74708351 |
| 102 | establishment of endothelial barrier (GO:0061028) | 2.73113531 |
| 103 | myofibril assembly (GO:0030239) | 2.72376112 |
| 104 | * patterning of blood vessels (GO:0001569) | 2.71894154 |
| 105 | * vasculogenesis (GO:0001570) | 2.70335219 |
| 106 | adenosine receptor signaling pathway (GO:0001973) | 2.70259093 |
| 107 | lipid oxidation (GO:0034440) | 2.70045889 |
| 108 | oxaloacetate metabolic process (GO:0006107) | 2.69959100 |
| 109 | angiogenesis involved in wound healing (GO:0060055) | 2.69125204 |
| 110 | collagen metabolic process (GO:0032963) | 2.67417249 |
| 111 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66366746 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66171962 |
| 113 | protein carboxylation (GO:0018214) | 2.65906815 |
| 114 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.65906815 |
| 115 | fatty acid catabolic process (GO:0009062) | 2.65060491 |
| 116 | cell adhesion mediated by integrin (GO:0033627) | 2.64745425 |
| 117 | collagen catabolic process (GO:0030574) | 2.63691160 |
| 118 | complement activation, alternative pathway (GO:0006957) | 2.63514304 |
| 119 | plasma membrane repair (GO:0001778) | 2.63076565 |
| 120 | alpha-linolenic acid metabolic process (GO:0036109) | 2.62522726 |
| 121 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61957436 |
| 122 | endothelial cell migration (GO:0043542) | 2.61830682 |
| 123 | regulation of cholesterol storage (GO:0010885) | 2.60368224 |
| 124 | peptide catabolic process (GO:0043171) | 2.59512340 |
| 125 | response to interferon-alpha (GO:0035455) | 2.58771501 |
| 126 | adhesion of symbiont to host (GO:0044406) | 2.58390279 |
| 127 | regulation of protein activation cascade (GO:2000257) | 2.58241696 |
| 128 | regulation of complement activation (GO:0030449) | 2.57055952 |
| 129 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.57007903 |
| 130 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.56971373 |
| 131 | positive regulation of focal adhesion assembly (GO:0051894) | 2.56865369 |
| 132 | positive regulation of cell junction assembly (GO:1901890) | 2.56865369 |
| 133 | blood coagulation, intrinsic pathway (GO:0007597) | 2.54557310 |
| 134 | low-density lipoprotein particle clearance (GO:0034383) | 2.53751866 |
| 135 | oligosaccharide catabolic process (GO:0009313) | 2.52811263 |
| 136 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.52667909 |
| 137 | regulation of fatty acid oxidation (GO:0046320) | 2.52571304 |
| 138 | tricarboxylic acid cycle (GO:0006099) | 2.52485515 |
| 139 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.51909308 |
| 140 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.51541526 |
| 141 | regulation of p38MAPK cascade (GO:1900744) | 2.51520769 |
| 142 | embryonic heart tube development (GO:0035050) | 2.50788180 |
| 143 | tooth mineralization (GO:0034505) | 2.50265716 |
| 144 | decidualization (GO:0046697) | 2.50030500 |
| 145 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.49399322 |
| 146 | carnitine metabolic process (GO:0009437) | 2.48538045 |
| 147 | negative regulation of vascular permeability (GO:0043116) | 2.47724781 |
| 148 | trabecula formation (GO:0060343) | 2.47652421 |
| 149 | regulation of fibrinolysis (GO:0051917) | 2.47173998 |
| 150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.47102291 |
| 151 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.47028677 |
| 152 | ceramide catabolic process (GO:0046514) | 2.47022230 |
| 153 | amino-acid betaine metabolic process (GO:0006577) | 2.46971177 |
| 154 | regulation of vascular permeability (GO:0043114) | 2.46826842 |
| 155 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.46202666 |
| 156 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.45798710 |
| 157 | L-phenylalanine metabolic process (GO:0006558) | 2.45798710 |
| 158 | multicellular organismal catabolic process (GO:0044243) | 2.44362845 |
| 159 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43722058 |
| 160 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.43154567 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.41647895 |
| 162 | response to laminar fluid shear stress (GO:0034616) | 2.40329541 |
| 163 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39029693 |
| 164 | chondrocyte proliferation (GO:0035988) | 2.38940897 |
| 165 | regulation of mast cell degranulation (GO:0043304) | 2.38795233 |
| 166 | N-acetylneuraminate metabolic process (GO:0006054) | 2.37881033 |
| 167 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.37873706 |
| 168 | membrane lipid catabolic process (GO:0046466) | 2.37796355 |
| 169 | embryo implantation (GO:0007566) | 2.37794482 |
| 170 | cortical actin cytoskeleton organization (GO:0030866) | 2.37744751 |
| 171 | response to progesterone (GO:0032570) | 2.36206336 |
| 172 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34946476 |
| 173 | * extracellular matrix disassembly (GO:0022617) | 2.34677802 |
| 174 | regulation of leukocyte degranulation (GO:0043300) | 2.33946356 |
| 175 | monocyte chemotaxis (GO:0002548) | 2.33858088 |
| 176 | multicellular organismal metabolic process (GO:0044236) | 2.31393630 |
| 177 | neutrophil activation involved in immune response (GO:0002283) | 2.30768851 |
| 178 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.30461845 |
| 179 | positive regulation of odontogenesis (GO:0042482) | 2.30118771 |
| 180 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.29351474 |
| 181 | regulation of macrophage cytokine production (GO:0010935) | 2.29346573 |
| 182 | regulation of smooth muscle cell migration (GO:0014910) | 2.27247475 |
| 183 | macrophage activation involved in immune response (GO:0002281) | 2.27130895 |
| 184 | sphingolipid catabolic process (GO:0030149) | 2.25476347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.95251733 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.23760976 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33534039 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.62494234 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.27545851 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.04165362 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.01256195 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91489462 |
| 9 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.84395076 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.64529134 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63308045 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.58187102 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49239655 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45166612 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.41826693 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29250702 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.15556603 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05330032 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03283686 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01232987 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99297247 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97615499 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94612461 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90680191 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89210062 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87944181 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85243994 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.84180003 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.84180003 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77322211 |
| 31 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75451088 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75420427 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70852104 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69709086 |
| 35 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69519698 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68263140 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67089289 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.66528857 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64906376 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60423808 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.55714788 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50073674 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46663303 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45891489 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44723171 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38411869 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38245696 |
| 48 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34996838 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34630815 |
| 50 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34310551 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33688606 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33046131 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32802363 |
| 54 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.31457239 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.30952221 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30720731 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30661579 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29840496 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29036737 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28944942 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28472829 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27102669 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26463685 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26417184 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25198376 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25046412 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24604434 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24027672 |
| 69 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22521775 |
| 70 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21937646 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21753965 |
| 72 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.21097023 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20847264 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18713820 |
| 75 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18306390 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16839770 |
| 77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16319016 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14947078 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14591310 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14304621 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12793969 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11829770 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10747295 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10216329 |
| 85 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09901726 |
| 86 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09736310 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09551452 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09270353 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08607711 |
| 90 | * MYC_22102868_ChIP-Seq_BL_Human | 1.08104370 |
| 91 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.07637761 |
| 92 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.07495405 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06993846 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05228053 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03442407 |
| 96 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.03348514 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03022933 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02548709 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01803167 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00990131 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00760061 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00713364 |
| 103 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.00032000 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99617608 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99230839 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98508289 |
| 107 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98439274 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98378523 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98340967 |
| 110 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98051961 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96585057 |
| 112 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96263747 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95688916 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95286600 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94446891 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93436736 |
| 117 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92707737 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92567118 |
| 119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92521077 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92185995 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91764998 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91103014 |
| 123 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.90555191 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90006740 |
| 125 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.89551252 |
| 126 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89449449 |
| 127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88670650 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88664524 |
| 129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87958661 |
| 130 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.86943480 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86778187 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86700904 |
| 133 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83980048 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83751793 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83096713 |
| 136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82514328 |
| 137 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82295921 |
| 138 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.82073279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.29617699 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 4.36172466 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.03258973 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.38666734 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 3.18618539 |
| 6 | MP0004272_abnormal_basement_membrane | 3.03525844 |
| 7 | MP0003724_increased_susceptibility_to | 3.02463322 |
| 8 | MP0003828_pulmonary_edema | 2.63818618 |
| 9 | MP0006054_spinal_hemorrhage | 2.33966080 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.20248532 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.16731481 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.07671615 |
| 13 | MP0003436_decreased_susceptibility_to | 2.07600074 |
| 14 | MP0005360_urolithiasis | 2.06873236 |
| 15 | MP0006082_CNS_inflammation | 2.04635410 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.03417244 |
| 17 | MP0000751_myopathy | 2.02861776 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.00933396 |
| 19 | MP0003279_aneurysm | 1.97410566 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.95767557 |
| 21 | MP0006138_congestive_heart_failure | 1.93206619 |
| 22 | MP0005257_abnormal_intraocular_pressure | 1.86211021 |
| 23 | MP0005330_cardiomyopathy | 1.85261064 |
| 24 | MP0002998_abnormal_bone_remodeling | 1.85253039 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.81144370 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.80792436 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.77810054 |
| 28 | MP0004130_abnormal_muscle_cell | 1.75475119 |
| 29 | MP0003091_abnormal_cell_migration | 1.75170496 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.74918470 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.74675525 |
| 32 | MP0005365_abnormal_bile_salt | 1.74435829 |
| 33 | MP0000343_altered_response_to | 1.73939789 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.73834588 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.73834588 |
| 36 | MP0001542_abnormal_bone_strength | 1.71965697 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.71376798 |
| 38 | MP0001958_emphysema | 1.70592041 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.70429021 |
| 40 | MP0000604_amyloidosis | 1.66830878 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.65955742 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.63921038 |
| 43 | MP0002933_joint_inflammation | 1.62554793 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.61185666 |
| 45 | MP0002419_abnormal_innate_immunity | 1.61135972 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.56855337 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56508030 |
| 48 | MP0003448_altered_tumor_morphology | 1.49473746 |
| 49 | MP0000749_muscle_degeneration | 1.43519882 |
| 50 | * MP0000767_abnormal_smooth_muscle | 1.43479693 |
| 51 | MP0005670_abnormal_white_adipose | 1.42531663 |
| 52 | MP0004147_increased_porphyrin_level | 1.40485011 |
| 53 | MP0005165_increased_susceptibility_to | 1.40236628 |
| 54 | MP0003252_abnormal_bile_duct | 1.39506820 |
| 55 | MP0009785_altered_susceptibility_to | 1.38994679 |
| 56 | MP0002972_abnormal_cardiac_muscle | 1.37224866 |
| 57 | MP0000249_abnormal_blood_vessel | 1.36991388 |
| 58 | MP0001849_ear_inflammation | 1.34199416 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.31060851 |
| 60 | MP0005390_skeleton_phenotype | 1.28457673 |
| 61 | * MP0002128_abnormal_blood_circulation | 1.28259699 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.27977888 |
| 63 | MP0000858_altered_metastatic_potential | 1.27603675 |
| 64 | MP0003646_muscle_fatigue | 1.27079316 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.26291386 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.23413428 |
| 67 | MP0005025_abnormal_response_to | 1.23013155 |
| 68 | MP0009840_abnormal_foam_cell | 1.22310662 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.20586566 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.19274171 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.19198606 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.18484954 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.18484954 |
| 74 | MP0009278_abnormal_bone_marrow | 1.17833770 |
| 75 | MP0001853_heart_inflammation | 1.17192823 |
| 76 | MP0005387_immune_system_phenotype | 1.15084673 |
| 77 | MP0001790_abnormal_immune_system | 1.15084673 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.14269933 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.12991407 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.12147096 |
| 81 | MP0005508_abnormal_skeleton_morphology | 1.11913510 |
| 82 | MP0004484_altered_response_of | 1.11207999 |
| 83 | MP0003329_amyloid_beta_deposits | 1.11005420 |
| 84 | MP0005451_abnormal_body_composition | 1.09148768 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 1.08468840 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.06679462 |
| 87 | MP0005332_abnormal_amino_acid | 1.05501668 |
| 88 | MP0004858_abnormal_nervous_system | 1.05215189 |
| 89 | MP0005620_abnormal_muscle_contractility | 1.05020397 |
| 90 | MP0000013_abnormal_adipose_tissue | 1.04165349 |
| 91 | MP0005166_decreased_susceptibility_to | 1.03712285 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 1.03061318 |
| 93 | MP0004510_myositis | 1.02787497 |
| 94 | * MP0001614_abnormal_blood_vessel | 1.02591532 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.02391437 |
| 96 | MP0005666_abnormal_adipose_tissue | 1.01579443 |
| 97 | MP0000230_abnormal_systemic_arterial | 1.00532756 |
| 98 | MP0008260_abnormal_autophagy | 0.98617189 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.98213838 |
| 100 | MP0003795_abnormal_bone_structure | 0.98114553 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.97242670 |
| 102 | MP0003303_peritoneal_inflammation | 0.96975988 |
| 103 | MP0003690_abnormal_glial_cell | 0.96230219 |
| 104 | MP0005275_abnormal_skin_tensile | 0.94452481 |
| 105 | MP0005409_darkened_coat_color | 0.94355501 |
| 106 | * MP0002925_abnormal_cardiovascular_devel | 0.91924557 |
| 107 | * MP0000266_abnormal_heart_morphology | 0.91886549 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.91833234 |
| 109 | MP0000609_abnormal_liver_physiology | 0.91805418 |
| 110 | MP0002254_reproductive_system_inflammat | 0.91044030 |
| 111 | * MP0005595_abnormal_vascular_smooth | 0.90913595 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.90893162 |
| 113 | MP0004233_abnormal_muscle_weight | 0.90861373 |
| 114 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90808494 |
| 115 | * MP0004085_abnormal_heartbeat | 0.90160978 |
| 116 | MP0002405_respiratory_system_inflammati | 0.89386620 |
| 117 | MP0004947_skin_inflammation | 0.88027902 |
| 118 | MP0002452_abnormal_antigen_presenting | 0.87898332 |
| 119 | MP0002106_abnormal_muscle_physiology | 0.87860813 |
| 120 | MP0004883_abnormal_blood_vessel | 0.87765166 |
| 121 | MP0005083_abnormal_biliary_tract | 0.86632951 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.85387869 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.85247193 |
| 124 | MP0000920_abnormal_myelination | 0.83810055 |
| 125 | MP0005023_abnormal_wound_healing | 0.83572567 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.82841449 |
| 127 | MP0008004_abnormal_stomach_pH | 0.82720121 |
| 128 | MP0001756_abnormal_urination | 0.81445542 |
| 129 | MP0002118_abnormal_lipid_homeostasis | 0.81131172 |
| 130 | MP0000598_abnormal_liver_morphology | 0.80480431 |
| 131 | MP0001243_abnormal_dermal_layer | 0.79624591 |
| 132 | MP0001915_intracranial_hemorrhage | 0.79322202 |
| 133 | MP0002269_muscular_atrophy | 0.79292209 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.78083424 |
| 135 | MP0010155_abnormal_intestine_physiology | 0.78020648 |
| 136 | MP0009764_decreased_sensitivity_to | 0.77548385 |
| 137 | MP0002723_abnormal_immune_serum | 0.75727596 |
| 138 | MP0003943_abnormal_hepatobiliary_system | 0.75019208 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.74316243 |
| 140 | MP0003634_abnormal_glial_cell | 0.72374358 |
| 141 | MP0000747_muscle_weakness | 0.72241828 |
| 142 | MP0005164_abnormal_response_to | 0.72125070 |
| 143 | MP0008469_abnormal_protein_level | 0.72042956 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.71887128 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.71807745 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.71158642 |
| 147 | MP0002060_abnormal_skin_morphology | 0.69987705 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69760864 |
| 149 | MP0005369_muscle_phenotype | 0.68927653 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.68897353 |
| 151 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68057727 |
| 152 | MP0003075_altered_response_to | 0.68009009 |
| 153 | MP0000685_abnormal_immune_system | 0.66742122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.46897492 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.46897492 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.46897492 |
| 4 | Dysostosis multiplex (HP:0000943) | 4.25649844 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.20880421 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.11384921 |
| 7 | * Polycythemia (HP:0001901) | 4.07522741 |
| 8 | Broad metatarsal (HP:0001783) | 3.79152582 |
| 9 | Sudden death (HP:0001699) | 3.77938875 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.54719303 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.54719303 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.54719303 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.46176421 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.45608308 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.44914057 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.44914057 |
| 17 | Lymphangioma (HP:0100764) | 3.42502456 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.40535587 |
| 19 | Protrusio acetabuli (HP:0003179) | 3.39413592 |
| 20 | Nonimmune hydrops fetalis (HP:0001790) | 3.38622940 |
| 21 | Increased connective tissue (HP:0009025) | 3.36163712 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.27703814 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.27597798 |
| 24 | Axonal loss (HP:0003447) | 3.21336962 |
| 25 | Lipoatrophy (HP:0100578) | 3.14383838 |
| 26 | Atrial fibrillation (HP:0005110) | 3.12298094 |
| 27 | Mesangial abnormality (HP:0001966) | 3.10301181 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.05091081 |
| 29 | Nuclear cataract (HP:0100018) | 3.04569707 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.00223665 |
| 31 | Supraventricular arrhythmia (HP:0005115) | 2.96677577 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 2.95617058 |
| 33 | Loss of speech (HP:0002371) | 2.92880348 |
| 34 | Cervical subluxation (HP:0003308) | 2.88367810 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.87247992 |
| 36 | Vascular tortuosity (HP:0004948) | 2.86740281 |
| 37 | Primary atrial arrhythmia (HP:0001692) | 2.86055426 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84679174 |
| 39 | * Esophageal varix (HP:0002040) | 2.83553506 |
| 40 | Supraventricular tachycardia (HP:0004755) | 2.81210368 |
| 41 | Joint stiffness (HP:0001387) | 2.78371564 |
| 42 | Spondylolisthesis (HP:0003302) | 2.73849238 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.72248905 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.71042520 |
| 45 | * Abnormality of the nasal mucosa (HP:0000433) | 2.70434772 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.69852966 |
| 47 | Joint hemorrhage (HP:0005261) | 2.69148259 |
| 48 | Aortic aneurysm (HP:0004942) | 2.68599582 |
| 49 | Complement deficiency (HP:0004431) | 2.67861173 |
| 50 | Atrioventricular block (HP:0001678) | 2.65205016 |
| 51 | Ketosis (HP:0001946) | 2.62583194 |
| 52 | Dilated cardiomyopathy (HP:0001644) | 2.61525303 |
| 53 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60689136 |
| 54 | Subaortic stenosis (HP:0001682) | 2.60689136 |
| 55 | Myoglobinuria (HP:0002913) | 2.59327320 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.58774542 |
| 57 | Arterial tortuosity (HP:0005116) | 2.57707564 |
| 58 | Hyperammonemia (HP:0001987) | 2.55253282 |
| 59 | Ketoacidosis (HP:0001993) | 2.54518277 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.50640048 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.48335679 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.42823126 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.42817873 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40095405 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.40095405 |
| 66 | Xanthomatosis (HP:0000991) | 2.39811357 |
| 67 | Myocardial infarction (HP:0001658) | 2.39573333 |
| 68 | Intrahepatic cholestasis (HP:0001406) | 2.38518421 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.37733936 |
| 70 | Abnormal platelet function (HP:0011869) | 2.37733936 |
| 71 | Exercise-induced muscle cramps (HP:0003710) | 2.37352823 |
| 72 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.36756341 |
| 73 | Wormian bones (HP:0002645) | 2.36018101 |
| 74 | Blue sclerae (HP:0000592) | 2.35997227 |
| 75 | Dilatation of the ascending aorta (HP:0005111) | 2.35473216 |
| 76 | Genu recurvatum (HP:0002816) | 2.34132335 |
| 77 | Chondrocalcinosis (HP:0000934) | 2.33914493 |
| 78 | Disinhibition (HP:0000734) | 2.33097825 |
| 79 | Mutism (HP:0002300) | 2.32601823 |
| 80 | * Spontaneous hematomas (HP:0007420) | 2.30929378 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.28957140 |
| 82 | Bladder diverticulum (HP:0000015) | 2.28497566 |
| 83 | Palpitations (HP:0001962) | 2.28031831 |
| 84 | Nephritis (HP:0000123) | 2.26147977 |
| 85 | Upper motor neuron abnormality (HP:0002127) | 2.25812382 |
| 86 | Hyperlipoproteinemia (HP:0010980) | 2.25314049 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.23962227 |
| 88 | Slender build (HP:0001533) | 2.23747835 |
| 89 | Soft skin (HP:0000977) | 2.22055375 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.21710963 |
| 91 | Difficulty running (HP:0009046) | 2.21173705 |
| 92 | Wrist flexion contracture (HP:0001239) | 2.20962978 |
| 93 | * Aneurysm (HP:0002617) | 2.20284324 |
| 94 | Calf muscle hypertrophy (HP:0008981) | 2.19702046 |
| 95 | Aortic dissection (HP:0002647) | 2.16990600 |
| 96 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15498817 |
| 97 | Rhabdomyolysis (HP:0003201) | 2.15194483 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.14968671 |
| 99 | Atrophic scars (HP:0001075) | 2.14861503 |
| 100 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14639208 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 2.12469487 |
| 102 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12390147 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 2.11978083 |
| 104 | Abnormality of Sharpey fibers (HP:0100685) | 2.11035223 |
| 105 | Cardiovascular calcification (HP:0011915) | 2.10971536 |
| 106 | Pulmonary artery stenosis (HP:0004415) | 2.10124728 |
| 107 | Hyperglycinuria (HP:0003108) | 2.10061930 |
| 108 | Purpura (HP:0000979) | 2.09983583 |
| 109 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.09935355 |
| 110 | Delayed CNS myelination (HP:0002188) | 2.09257619 |
| 111 | Fragile skin (HP:0001030) | 2.08962484 |
| 112 | Glomerulonephritis (HP:0000099) | 2.08892699 |
| 113 | * Hematochezia (HP:0002573) | 2.07290482 |
| 114 | Heart block (HP:0012722) | 2.06964912 |
| 115 | Aortic valve stenosis (HP:0001650) | 2.06879959 |
| 116 | Peritonitis (HP:0002586) | 2.06268755 |
| 117 | Achilles tendon contracture (HP:0001771) | 2.05240949 |
| 118 | Abnormality of complement system (HP:0005339) | 2.04508009 |
| 119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04246546 |
| 120 | Neonatal death (HP:0003811) | 2.01973373 |
| 121 | Thin bony cortex (HP:0002753) | 2.01936157 |
| 122 | Abnormal atrioventricular conduction (HP:0005150) | 2.01203324 |
| 123 | Distal upper limb amyotrophy (HP:0007149) | 2.00313832 |
| 124 | Upper limb amyotrophy (HP:0009129) | 2.00313832 |
| 125 | J-shaped sella turcica (HP:0002680) | 2.00265165 |
| 126 | Ovoid vertebral bodies (HP:0003300) | 1.99525229 |
| 127 | Apathy (HP:0000741) | 1.99437342 |
| 128 | Neoplasm of head and neck (HP:0012288) | 1.98531791 |
| 129 | Esophageal neoplasm (HP:0100751) | 1.98531791 |
| 130 | Follicular hyperkeratosis (HP:0007502) | 1.98530037 |
| 131 | Vascular calcification (HP:0004934) | 1.98451444 |
| 132 | Difficulty climbing stairs (HP:0003551) | 1.98190089 |
| 133 | Eczematoid dermatitis (HP:0000976) | 1.97942359 |
| 134 | Hypoalphalipoproteinemia (HP:0003233) | 1.97844350 |
| 135 | Distal lower limb amyotrophy (HP:0008944) | 1.97692746 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.96101736 |
| 137 | Diminished motivation (HP:0000745) | 1.93823982 |
| 138 | Shallow orbits (HP:0000586) | 1.93676293 |
| 139 | Facial diplegia (HP:0001349) | 1.92941765 |
| 140 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92441649 |
| 141 | Myotonia (HP:0002486) | 1.92075778 |
| 142 | * Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90973688 |
| 143 | Osteolytic defects of the hand bones (HP:0009699) | 1.90541459 |
| 144 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90541459 |
| 145 | Syncope (HP:0001279) | 1.90215419 |
| 146 | Prolonged partial thromboplastin time (HP:0003645) | 1.88973413 |
| 147 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88805937 |
| 148 | Menorrhagia (HP:0000132) | 1.86347939 |
| 149 | Abnormality of the calf musculature (HP:0001430) | 1.84806429 |
| 150 | Pathologic fracture (HP:0002756) | 1.83875404 |
| 151 | Recurrent abscess formation (HP:0002722) | 1.82186970 |
| 152 | Ankle contracture (HP:0006466) | 1.81794833 |
| 153 | Spinal rigidity (HP:0003306) | 1.80717238 |
| 154 | Gout (HP:0001997) | 1.80150166 |
| 155 | Hyperactive renin-angiotensin system (HP:0000841) | 1.79676440 |
| 156 | Premature rupture of membranes (HP:0001788) | 1.79383697 |
| 157 | Abnormality of the Achilles tendon (HP:0005109) | 1.79372583 |
| 158 | Generalized amyotrophy (HP:0003700) | 1.78983124 |
| 159 | Aortic regurgitation (HP:0001659) | 1.78699543 |
| 160 | Amyloidosis (HP:0011034) | 1.77772041 |
| 161 | Generalized muscle weakness (HP:0003324) | 1.77532039 |
| 162 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77262013 |
| 163 | Increased serum ferritin (HP:0003281) | 1.77144961 |
| 164 | Abnormality of dentin (HP:0010299) | 1.75839662 |
| 165 | Ragged-red muscle fibers (HP:0003200) | 1.75612606 |
| 166 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75237904 |
| 167 | Abnormality of glycine metabolism (HP:0010895) | 1.75095630 |
| 168 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75095630 |
| 169 | Joint laxity (HP:0001388) | 1.74809641 |
| 170 | Bone pain (HP:0002653) | 1.73225541 |
| 171 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72591782 |
| 172 | Progressive neurologic deterioration (HP:0002344) | 1.71035141 |
| 173 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70855728 |
| 174 | Emphysema (HP:0002097) | 1.70082790 |
| 175 | Coxa vara (HP:0002812) | 1.68395531 |
| 176 | Abnormality of the acetabulum (HP:0003170) | 1.67929461 |
| 177 | Mitral regurgitation (HP:0001653) | 1.67502718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.94124716 |
| 2 | KDR | 6.21398067 |
| 3 | ERN1 | 3.02931449 |
| 4 | DDR2 | 2.74011290 |
| 5 | IRAK3 | 2.60094741 |
| 6 | PKN2 | 2.38777758 |
| 7 | MYLK | 2.33174442 |
| 8 | BCKDK | 2.33008381 |
| 9 | TRIB3 | 2.32188107 |
| 10 | TESK1 | 2.10716110 |
| 11 | TTN | 2.07412593 |
| 12 | * TGFBR2 | 1.99974814 |
| 13 | RIPK1 | 1.93260165 |
| 14 | MAP2K3 | 1.90216677 |
| 15 | PRPF4B | 1.79962276 |
| 16 | CDC42BPA | 1.75969169 |
| 17 | FGFR4 | 1.66557418 |
| 18 | KIT | 1.49813163 |
| 19 | TAOK2 | 1.48546721 |
| 20 | MOS | 1.45722153 |
| 21 | FLT3 | 1.41808311 |
| 22 | ABL2 | 1.41560941 |
| 23 | MAP3K13 | 1.40787216 |
| 24 | MAP3K14 | 1.37368103 |
| 25 | LIMK1 | 1.32822886 |
| 26 | EPHB2 | 1.32474309 |
| 27 | WNK4 | 1.32320907 |
| 28 | LRRK2 | 1.26409587 |
| 29 | EPHB1 | 1.22737344 |
| 30 | PTK2B | 1.19726186 |
| 31 | PTK6 | 1.19447291 |
| 32 | MAP4K1 | 1.12015769 |
| 33 | PAK4 | 1.11571253 |
| 34 | NME2 | 1.11096416 |
| 35 | PDGFRA | 1.09880231 |
| 36 | TBK1 | 1.08333650 |
| 37 | ICK | 1.07455579 |
| 38 | LATS2 | 1.05160285 |
| 39 | PRKG2 | 1.05005897 |
| 40 | MAPK12 | 1.02727564 |
| 41 | MAP3K3 | 1.01684417 |
| 42 | RPS6KA2 | 1.00232736 |
| 43 | NTRK1 | 0.98657505 |
| 44 | MAP3K11 | 0.97418737 |
| 45 | SIK1 | 0.96186162 |
| 46 | JAK3 | 0.94014673 |
| 47 | DMPK | 0.93609484 |
| 48 | GRK1 | 0.91167917 |
| 49 | TAOK1 | 0.90421074 |
| 50 | ARAF | 0.89184224 |
| 51 | PDK2 | 0.89005071 |
| 52 | TRPM7 | 0.85474443 |
| 53 | ZAP70 | 0.84820505 |
| 54 | FGR | 0.84411105 |
| 55 | PRKD1 | 0.84329821 |
| 56 | MAP3K7 | 0.83114740 |
| 57 | MAPKAPK3 | 0.81912786 |
| 58 | TEC | 0.79854761 |
| 59 | TESK2 | 0.76700924 |
| 60 | LMTK2 | 0.76349165 |
| 61 | TYK2 | 0.76258999 |
| 62 | MARK2 | 0.71648148 |
| 63 | RPS6KC1 | 0.70770459 |
| 64 | RPS6KL1 | 0.70770459 |
| 65 | MUSK | 0.69439981 |
| 66 | STK10 | 0.68526443 |
| 67 | SMG1 | 0.68453148 |
| 68 | CSF1R | 0.67559815 |
| 69 | FER | 0.66134112 |
| 70 | MAP3K10 | 0.65417937 |
| 71 | CAMKK2 | 0.64833195 |
| 72 | CSK | 0.64624344 |
| 73 | PHKG1 | 0.62188175 |
| 74 | PHKG2 | 0.62188175 |
| 75 | MATK | 0.61942291 |
| 76 | MAPK15 | 0.61767534 |
| 77 | EEF2K | 0.61177420 |
| 78 | CAMK4 | 0.61080480 |
| 79 | PRKAA2 | 0.60615068 |
| 80 | PDK4 | 0.59261606 |
| 81 | PDK3 | 0.59261606 |
| 82 | RIPK4 | 0.58785019 |
| 83 | JAK1 | 0.58393407 |
| 84 | INSRR | 0.57277409 |
| 85 | IKBKB | 0.55799233 |
| 86 | FGFR3 | 0.55348713 |
| 87 | PIK3CA | 0.54653788 |
| 88 | JAK2 | 0.54600523 |
| 89 | ROCK1 | 0.54243554 |
| 90 | CAMK1D | 0.53794359 |
| 91 | NEK9 | 0.53401728 |
| 92 | MAP3K1 | 0.52700591 |
| 93 | HCK | 0.52447739 |
| 94 | RET | 0.48700755 |
| 95 | ILK | 0.48470428 |
| 96 | BTK | 0.48262527 |
| 97 | PAK2 | 0.48151143 |
| 98 | IRAK4 | 0.47739364 |
| 99 | OBSCN | 0.46383436 |
| 100 | ROCK2 | 0.46369905 |
| 101 | IKBKE | 0.44603544 |
| 102 | RPS6KA4 | 0.44467376 |
| 103 | PRKD2 | 0.43608347 |
| 104 | PTK2 | 0.42823234 |
| 105 | CAMK1 | 0.42505258 |
| 106 | MAPK11 | 0.41455957 |
| 107 | PINK1 | 0.39947484 |
| 108 | MAPK4 | 0.38978749 |
| 109 | KSR2 | 0.38333342 |
| 110 | PRKCH | 0.38230103 |
| 111 | SRC | 0.37135098 |
| 112 | EPHA3 | 0.36478841 |
| 113 | STK38 | 0.35529565 |
| 114 | LYN | 0.33985193 |
| 115 | GRK7 | 0.33838688 |
| 116 | CHUK | 0.32699320 |
| 117 | LCK | 0.32480842 |
| 118 | SYK | 0.31749552 |
| 119 | MAPK7 | 0.31589103 |
| 120 | IGF1R | 0.31289624 |
| 121 | EGFR | 0.31056642 |
| 122 | PIM2 | 0.31049569 |
| 123 | FES | 0.28992977 |
| 124 | PDGFRB | 0.28712179 |
| 125 | DAPK3 | 0.28096761 |
| 126 | GSK3A | 0.27484757 |
| 127 | MET | 0.26964060 |
| 128 | TAOK3 | 0.26963201 |
| 129 | MTOR | 0.26856960 |
| 130 | MAP2K2 | 0.26163367 |
| 131 | CAMK1G | 0.25070191 |
| 132 | BLK | 0.23290776 |
| 133 | PDPK1 | 0.22284132 |
| 134 | MAP2K6 | 0.21530024 |
| 135 | MAP3K6 | 0.21076568 |
| 136 | NLK | 0.21011698 |
| 137 | RPS6KA6 | 0.20953381 |
| 138 | PRKAA1 | 0.20308150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.15300221 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.10359247 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.98776978 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.89929658 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61001666 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54784880 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.54524115 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.52028565 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43532132 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.32011264 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15663825 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04434986 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.03864498 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02572848 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02258036 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02097154 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01123632 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.93964973 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.93915253 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88351713 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74408717 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.71088973 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.65603683 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.63063017 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.56183039 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55233082 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.53716881 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52275329 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50180198 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.49499578 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48917804 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.48841175 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.43949592 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.42598766 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41516795 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.37852895 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.37675183 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34475892 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32372869 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27525092 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26450075 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22665508 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.16760635 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13913088 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11095491 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10997671 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.09002934 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.07854446 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.05698136 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.04241834 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02313992 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02293864 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00795607 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00440352 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.98801111 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.98371689 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97614279 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97543786 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97340826 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96759459 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95631578 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95226094 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94802306 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94242124 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.91343576 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91015037 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90532340 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88501886 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87490770 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.87300752 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.85987005 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85356712 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85242470 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84347552 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84308887 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84263162 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83973264 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83360214 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82292047 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81878291 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80927988 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79726883 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78935555 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78916252 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78078323 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77598946 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76745636 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76546106 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76307341 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76035787 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75761467 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.75241023 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75086674 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.74476893 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.74198659 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72774268 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72517314 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71452480 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70838323 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68885973 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.68538094 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68103086 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67322964 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.67162450 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65830519 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65774608 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.64188871 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64075294 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63420990 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62620517 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62547318 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62115769 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61767795 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.60501291 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58646293 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57919981 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57731421 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57556183 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57086428 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57067116 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55962672 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55596222 |
| 123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53012711 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52664388 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51534065 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51039444 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49357350 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49174812 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47928632 |
| 130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47905021 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.47653065 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47581953 |
| 133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46628852 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46500371 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44895072 |
| 136 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44498919 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44098008 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43404837 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43165461 |
| 140 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43135048 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42037593 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40910402 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40683893 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40446641 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40418341 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40217696 |
| 147 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40090359 |
| 148 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39718302 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39496067 |
| 150 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39398815 |
| 151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39017579 |
| 152 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37984007 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37628402 |
| 154 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37541464 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37033786 |
| 156 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36402645 |
| 157 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35644059 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34551097 |
| 159 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33022699 |
| 160 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32299684 |
| 161 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31243405 |

